Detalhe da pesquisa
1.
Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia.
Leukemia
; 18(3): 484-90, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-14749699
2.
Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies.
Hematol J
; 2(5): 300-6, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11920265
3.
T-cell signaling and costimulatory molecules in B-chronic lymphocytic leukemia (B-CLL): an increased abnormal expression by advancing stage.
Leukemia
; 17(11): 2252-4, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14576733
4.
Kinetics of cytokine gene expression in human CD4+ and CD8+ T-lymphocyte subsets using quantitative real-time PCR.
Scand J Immunol
; 58(6): 601-6, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14636415